Antibacterial Drugs Market
Antibacterial Drugs Market Analysis by Drug Class (?-lactam, Quinolone, Macrolide, Tetracycline Antibacterial Drugs), by Route of Administration (Enteral, Parenteral Antibacterial Drug Administration), by Distribution Channel & by Region - Global Insights 2021 to 2031
Analysis of Antibacterial Drugs Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Assumptions and Acronyms Used 2. Research Methodology 3. Executive Summary 4. Market Overview 4.1. Product Overview 4.2. Key Industry Developments 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity Analysis 4.3.4. Porter’s Five Forces Representation 4.3.5. Antibacterial Drugs Market- Value Chain Analysis & Supply-Demand Scenario 4.3.6. Antibacterial Drugs Market Outlook 4.3.7. Anti-Bacterial Drugs Pipeline Analysis 5. Global Antibacterial Drugs Market Analysis, by Drug Class, 2021 – 2031 5.1. Key Findings 5.2. Definition 5.3. Introduction 5.4. Global Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031 5.5. Global Antibacterial Drugs Market Analysis, by Drug Class 5.5.1. β-lactam 5.5.2. Quinolones 5.5.3. Macrolides 5.5.4. Tetracycline 5.5.5. Aminoglycoside 5.5.6. Sulfonamide 5.5.7. Phenicols 5.5.8. Others 5.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Drug Class 5.7. Global Antibacterial Drugs Market Forecast, by Drug Class 5.8. Key Trends 6. Global Antibacterial Drugs Market Analysis, by Routes of Administration 6.1. Key Findings 6.2. Definitions 6.3. Introduction 6.4. Global Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031 6.5. Global Antibacterial Drugs Market Analysis, by Routes of Administration 6.5.1. Enteral 6.5.2. Parenteral 6.5.3. Others 6.6. Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration 6.7. Global Antibacterial Drugs Market Forecast, by Routes of Administration 7. Global Antibacterial Drugs Market Analysis, by Channels of Distribution 7.1. Key Findings 7.2. Definitions 7.3. Introduction 7.4. Global Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031 7.5. Global Antibacterial Drugs Market Analysis, by Channels of Distribution 7.5.1. Hospital Pharmacies 7.5.2. Drug Stores & Retail Pharmacies 7.5.3. Online Sales 7.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution 7.7. Global Antibacterial Drugs Market Forecast, by Channels of Distribution 7.8. Key Trends 8. Global Antibacterial Drugs Market Analysis, by Region 8.1. Key Findings 8.2. Introduction 8.3. Global Antibacterial Drugs Market Value Share Analysis, by Region, 2020 and 2031 8.4. Global Antibacterial Drugs Market Attractiveness Analysis, by Region, 2020 8.5. Global Antibacterial Drugs Market Forecast, by Region, 2021–2031 9. North America Antibacterial Drugs Market Analysis 9.1. North America Antibacterial Drugs Market Overview 9.2. North America Antibacterial Drugs Market Forecast, Country wise, 2021–2031 9.3. North America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031 9.4. North America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020 9.5. North America Antibacterial Drugs Market Forecast, by Drug Class, 2021–2031 9.6. North America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031 9.7. North America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020 9.8. North America Antibacterial Drugs Market Forecast, by Routes of Administration, 2021–2031 9.9. North America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031 9.10. North America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020 9.11. North America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2021–2031 9.12. Key Trends 10. Europe Antibacterial Drugs Market Analysis 10.1. Europe Antibacterial Drugs Market Overview 10.2. Europe Antibacterial Drugs Market Forecast, Country wise, 2021–2031 10.3. Europe Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031 10.4. Europe Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020 10.5. Europe Antibacterial Drugs Market Forecast, by Drug Class, 2021–2031 10.6. Europe Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031 10.7. Europe Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020 10.8. Europe Antibacterial Drugs Market Forecast, by Routes of Administration, 2021–2031 10.9. Europe Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031 10.10. Europe Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020 10.11. Europe Antibacterial Drugs Market Forecast, by Channels of Distributions, 2021–2031 10.12. Key Trends 11. Asia Pacific Antibacterial Drugs Market Analysis 11.1. Asia Pacific Antibacterial Drugs Market Overview 11.2. Asia Pacific Antibacterial Drugs Market Forecast, Country wise, 2021–2031 11.3. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031 11.4. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020 11.5. Asia Pacific Antibacterial Drugs Market Forecast, by Drug Class, 2021–2031 11.6. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031 11.7. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020 11.8. Asia Pacific Antibacterial Drugs Market Forecast, by Routes of Administration, 2021–2031 11.9. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031 11.10. Pacific Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020 11.11. Asia Pacific Antibacterial Drugs Market Forecast, by Channels of Distributions, 2021–2031 11.12. Key Trends 12. Latin America Antibacterial Drugs Market Analysis 12.1. Latin America Antibacterial Drugs Market Overview 12.2. Latin America Antibacterial Drugs Market Forecast, Country wise, 2021–2031 12.3. Latin America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031 12.4. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020 12.5. Latin America Antibacterial Drugs Market Forecast, by Drug Class, 2021–2031 12.6. Latin America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031 12.7. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020 12.8. Latin America Antibacterial Drugs Market Forecast, by Routes of Administration, 2021–2031 12.9. Latin America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031 12.10. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020 12.11. Latin America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2021–2031 12.12. Key Trends 13. Middle East & Africa Antibacterial Drugs Market Analysis 13.1. Middle East & Africa Antibacterial Drugs Market Overview 13.2. Middle East & Africa Antibacterial Drugs Market Forecast, Country wise, 2021–2031 13.3. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031 13.4. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020 13.5. Middle East & Africa Antibacterial Drugs Market Forecast, by Drug Class, 2021–2031 13.6. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031 13.7. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020 13.8. Middle East & Africa Antibacterial Drugs Market Forecast, by Routes of Administration, 2021–2031 13.9. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031 13.10. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020 13.11. Middle East & Africa Antibacterial Drugs Market Forecast, by Channels of Distributions, 2021–2031 13.12. Key Trends 14. Competition Landscape 14.1. Leading Antibacterial Drugs Sales Analysis, 2014 – 2020 14.2. Competition Matrix 14.3. Company Profiles 14.3.1. Bayer AG 14.3.1.1. Company Description 14.3.1.2. Business Overview 14.3.1.3. SWOT Analysis 14.3.1.4. Strategic Overview 14.3.2. Pfizer Inc. 14.3.2.1. Company Description 14.3.2.2. Business Overview 14.3.2.3. SWOT Analysis 14.3.2.4. Strategic Overview 14.3.3. Sanofi 14.3.3.1. Company Description 14.3.3.2. Business Overview 14.3.3.3. SWOT Analysis 14.3.3.4. Strategic Overview 14.3.4. GlaxoSmithKline plc 14.3.4.1. Company Description 14.3.4.2. Business Overview 14.3.4.3. SWOT Analysis 14.3.4.4. Strategic Overview 14.3.5. Merck & Co., Inc 14.3.5.1. Company Description 14.3.5.2. Business Overview 14.3.5.3. SWOT Analysis 14.3.5.4. Strategic Overview 14.3.6. AstraZeneca 14.3.6.1. Company Description 14.3.6.2. Business Overview 14.3.6.3. SWOT Analysis 14.3.6.4. Strategic Overview 14.3.7. Johnson and Johnson 14.3.7.1. Company Description 14.3.7.2. Business Overview 14.3.7.3. SWOT Analysis 14.3.7.4. Strategic Overview 14.3.8. Bristol-Myers Squibb Company 14.3.8.1. Company Description 14.3.8.2. Business Overview 14.3.8.3. SWOT Analysis 14.3.8.4. Strategic Overview 14.3.9. Novartis AG 14.3.9.1. Company Description 14.3.9.2. Business Overview 14.3.9.3. SWOT Analysis 14.3.9.4. Strategic Overview 14.3.10. Allergen Plc. 14.3.10.1. Company Description 14.3.10.2. Business Overview 14.3.10.3. SWOT Analysis 14.3.10.4. Strategic Overview
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2021–2031
Table 02: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2021–2031
Table 03: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2021–2031
Table 04: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Region, 2021–2031
Table 05: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2021–2031
Table 06: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2021–2031
Table 07: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2021–2031
Table 08: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distributions, 2021–2031
Table 09: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2021–2031
Table 10: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2021–2031
Table 11: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2021–2031
Table 12: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2021–2031
Table 13: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2021–2031
Table 14: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2021–2031
Table 15: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2021–2031
Table 16: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2021–2031
Table 17: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Country Wise, 2021–2031
Table 18: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2021–2031
Table 19: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration,2021–2031
Table 20: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2021–2031
Table 21: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, by Country Wise, 2021–2031
Table 22: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2021–2031
Table 23: MEA Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2021–2031
Table 24: MEA Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2021–2031
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Antibacterial Drugs Market Size ($ Mn) and Distribution by Geography, 2017 and 2031
Figure 02: Global Antibacterial Drugs Market Revenue (US$ Mn) and top 3 trends
Figure 03: Global Antibacterial Drugs Market, by Channels of Distribution, Revenue (US$ Mn) and Market Share
Figure 04: Market Value Share By Drug Class (2017) Revenue (US$ Mn)
Figure 05: Market Value Share By Region (2017) Revenue (US$ Mn)
Figure 06: Antibacterial Drugs in Clinical Trials
Figure 07: Anti-bacterial Drugs by Indication
Figure 08: Anti-bacterial Drugs by class
Figure 09: Global Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031
Figure 10: Global β-lactam Market Revenue (US$ Mn) and Y-o-Y Growth (%), by β-lactam, 2021–2031
Figure 11: Global Quinolones Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 12: Global Macrolides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 13: Global Tetracyclines Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 14: Global Aminoglycosides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 15: Global Sulfonamides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 16: Global Phenicols Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 17: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 18: Global Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020
Figure 19: Global Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031
Figure 20: Global Enteral Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 21: Global Parenteral Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 22: Global Others routes of administration Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 23: Global Antibacterial Drugs Market Attractiveness Analysis, by Routes od Administration, 2020
Figure 24: Global Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031
Figure 25: Global Hospital Pharmacies Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 26: Global Drug Stores & Retail Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 27: Global Online Sales Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 28: Global Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020
Figure 29: Global Antibacterial Drugs Market Value Share Analysis, by Region, 2020 and 2031
Figure 30: Global Antibacterial Drugs Market Attractiveness Analysis, by Region, 2020
Figure 31: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, 2021–2031
Figure 32: North America Antibacterial Drugs Market Y-o-Y Growth Projections, 2021–2031
Figure 33: North America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031
Figure 34: North America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020
Figure 35: North America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031
Figure 36: North America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration,2020
Figure 37: North America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031
Figure 38: North America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020
Figure 39: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, 2021–2031
Figure 40: Europe Antibacterial Drugs Market Y-o-Y Growth Projections, 2021–2031
Figure 41: Europe Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031
Figure 42: Europe Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020
Figure 43: Europe Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031
Figure 44: Europe Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020
Figure 45: Europe Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031
Figure 46: Europe Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2020
Figure 47: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, 2021–2031
Figure 48: Asia Pacific Antibacterial Drugs Market Y-o-Y Growth Projections, 2017–2031
Figure 49: Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031
Figure 50: Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020
Figure 51: Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031
Figure 52: Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020
Figure 53: Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031
Figure 54: Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2020
Figure 55: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, 2021–2031
Figure 56: Latin America Antibacterial Drugs Market, Y-o-Y Growth Projection, 2021–2031
Figure 57: Latin America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031
Figure 58: Latin America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020
Figure 59: Latin America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031
Figure 60: Latin America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020
Figure 61: Latin America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031
Figure 62: Latin America Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2020
Figure 63: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, 2021–2031
Figure 64: Middle East & Africa Antibacterial Drugs Market Y-o-Y Growth Projections, 2021–2031
Figure 65: Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031
Figure 66: Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020
Figure 67: MEA Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031
Figure 68: MEA Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020
Figure 69: MEA Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031
Figure 70: MEA Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2020
Figure 71: Leading Antibacterial Drugs Sales Analysis, 2014 – 2020
Figure 72: Bayer AG, Breakdown of Net Sales, by Region, 2020
Figure 73: Bayer AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2020
Figure 74: Pfizer, Breakdown of Net Sales, by Region, 2020
Figure 75: Pfizer, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 76: Sanofi, Breakdown of Net Sales, by Region, 2020
Figure 77: Sanofi, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 78: GlaxoSmithKline, Breakdown of Net Sales, by Region, 2020
Figure 79: GlaxoSmithKline, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 80: Merck & Co., Breakdown of Net Sales, by Region, 2020
Figure 81: Merck & Co., Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2020
Figure 82: AstraZeneca, Breakdown of Net Sales, by Region, 2020
Figure 83: AstraZeneca, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 84: Johnson & Johnson, Breakdown of Net Sales, by Region, 2020
Figure 85: Johnson & Johnson, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 86: Bristol-Myers Squibb Company, Breakdown of Net Sales, by Region (2020)
Figure 87: Bristol-Myers Squibb Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 88: Novartis AG, Breakdown of Net Sales, by Region, 2020
Figure 89: Novartis AG, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 90: Allergen, Breakdown of Net Sales (%), by Segments (2020)
Figure 91: Allergen, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Antibacterial Drugs Market
*Mail attachment includes 91 figures & 24 tables